Patrick Gallagher

Patrick Gallagher is a seasoned executive in the biotechnology and healthcare sectors with extensive experience in leadership roles. Currently, Patrick serves as a Board Member and General Manager of Multiomics at Ovation, focusing on leveraging genomic and biological data for precision medicine. As Chief Executive Officer of Voltron Therapeutics, Patrick oversees a senior team dedicated to immuno-oncology and infectious disease targets. In addition to managing portfolios at Lucius Venture Partners, Patrick holds board positions at multiple companies, including Algorithm Sciences, BioSig Technologies, and Cingulate Therapeutics, contributing strategic direction and operational expertise. Patrick's previous role as CEO of PD Theranostics involved the integration of advanced technologies in diagnostics and therapeutics. Patrick holds an MBA from Penn State University and a Bachelor of Science in Finance from the University of Vermont.